HCT

Director Jeong Yeon-chun Increases Stake via Open Market Purchase... Small but Positive Signal


  • HCT registered director Jeong Yeon-chun acquired 1,150 common shares (at 4,385 won per share) via open market purchase on May 19, 2026, increasing total holdings to 2,185 shares (0.02% stake)
  • The acquisition price (4,385 won) is 7.6% above the current market price (4,075 won), reflecting management's confidence in the company's value
  • The purchase size is only 0.01% of total outstanding shares, limiting direct short-term price impact, but any insider buying is a positive signal for investor sentiment
  • [AI Comprehensive Analysis]This disclosure represents a minor change in insider holdings and does not materially alter enterprise value. While insider buying can be interpreted as a positive signal, the transaction size is negligible and insufficient as a primary basis for investment decisions.

KOSDAQ Filing Information


  • Filing: Report on Ownership of Specific Securities by Executives and Major Shareholders
  • Company: HCT (072990)
  • Submission: Jeong Yeon-chun
  • Receipt: 05-27-2026